1. de Villiers EM. Cross-roads in the classification of papillomaviruses. Virology 2013;445:2–10
2. Fuller C, Hudgins E, Finelt N. Human-papillomavirus-related disease in pediatrics. Curr Opin Pediatr. 2017;14: 10.1097.
3. Zur Hausen H. Papillomavirus infections—a major cause of human cancers. Biochimica et biophysica acta (BBA)-reviews on cancer. 1996;1288:F55-F78.
4. Marghoob AA, Malvehy J, Braun RP. An Atlas of Dermoscopy, Second Edition. CRC Press, 2012.
5. Harada K, Baillie R, Lu S, Syrjänen S, Schor AM. VEGF expression in skin warts. Relevance to angiogenesis and vasodilation, Arch. Dermatol. Res., 2001 May;293(5):233-8.
6. El-Nabarawy EA, El-Hanafy GM, Rashed LA, Yasin FS. Expression of angiopoietin-1, angiopoietin-2, and their receptor Tie2 in verruca vulgaris (common skin warts). Int J Dermatol. 2016 Jun;55(6):e327-31.7.
7. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med. 2003;3:643–51.
8. Müller AM, Hermanns MI, Skrzynski C, Nesslinger M, Müller KM, Kirkpatrick CJ. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol. 2002;72:221–9.
9. Fonsatti E, Nicolay HJ, Altomonte M, Covre A, Maio M. Targeting cancer vasculature via endoglin/CD105: A novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res. 2010;86:12–9
10. D.V. Parums, J.L. Cordell, K. Micklem, et al. A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections, J. Clin. Pathol. 43(9) (1990), 752–757.
11. L. Fina, H.V. Molgaard, D. Robertson, et al. Expression of the CD34 gene in vascular endothelial cells, Blood 15 75(12) (1990), 2417–2426.
12. Burrows FJ, Derbyshire EJ, Tazzari PL et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1: 1623–1634, 1995
13. Kumar S., Ghellal A., Li C., Byrne G., Haboubi N., Wang J. M., Bundred N. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res., 59: 856–861, 1999.
14. 21. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, et al. Evaluation of angiogenesis in non-small cell lung cancer: Comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res. 2001;7:3410–5.
15. Ryu Fukumitsu, Yasushi Takagi, Kazumichi Yoshida, Susumu Miyamoto. Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques. Surg Neurol Int. 2013; 4: 132.
16. Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny TV. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg. 2001;88:945–50.